TipRanks
Go Ultimate75% OFF

Humana AB (47H) Stock Price & Analysis

1 Followers

47H Stock Chart & Stats

€6.28€0.00(0.00%)
At close: 5:30 PM GMT+1
€4.2€4.3€4.4Mar 13Apr 14Jun 2
Day’s Range
EUR 6.28 - EUR 6.28
52-Week Range
EUR 3.76 - EUR 6.71
Previous Close
EUR 6.28
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 308.71M
Enterprise Value
EUR 7.50B
Total Cash (Recent Filing)
EUR 303.00M
Total Debt (Recent Filing)
EUR 4.42B
Price to Earnings (P/E)
19.1
Beta
0.41
Next Earnings
Feb 05, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
1.96%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Strong operating and free cash flow provide internal funding for care operations, investment, and debt service. Because free cash flow broadly tracks reported earnings, the company’s profit conversion appears reasonably sound and supports financial resilience over the next several quarters.

Stable Operations And Profitability

Broadly stable revenue and steady operating profitability indicate an established care-services platform with recurring operational activity. The TTM rebound and positive EBITDA provide a foundation for maintaining services and protecting earnings capacity if execution remains consistent.

Improving Equity Base

Gradual equity growth strengthens the capital base and provides some support against balance-sheet volatility. Although returns are moderate, positive ROE and improved leverage from earlier periods suggest the company has retained some capacity to build financial stability over time.

Bears Say

Debt-heavy Balance Sheet

Elevated leverage leaves less financial flexibility for a labor-intensive care provider and increases the importance of sustained cash generation. Debt exceeding equity, combined with limited operating-cash-flow coverage, could constrain investment and resilience during weaker operating periods.

Thin Net Profitability

A thin net margin leaves limited room to absorb cost increases or operational disruption without affecting earnings. The decline from earlier profitability levels makes future results more sensitive to changes in service economics, financing costs, and execution.

Weak Earnings Growth

Negative EPS growth indicates that earnings power has weakened despite broadly stable revenue. If this pattern persists, it could reduce internally generated capital, limit balance-sheet improvement, and make it harder for the company to expand profitably over the medium term.

Humana AB News

47H FAQ

What was Humana AB’s price range in the past 12 months?
Humana AB lowest stock price was €3.76 and its highest was €6.71 in the past 12 months.
What is Humana AB’s market cap?
Humana AB’s market cap is €308.71M.
When is Humana AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Humana AB’s earnings last quarter?
Humana AB released its earnings results on Oct 22, 2026. The company reported €0.235 earnings per share for the quarter, beating the consensus estimate of €0.204 by €0.031.
Is Humana AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Humana AB pay dividends?
Humana AB does not currently pay dividends.
What is Humana AB’s EPS estimate?
Humana AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Humana AB have?
Humana AB has 48,039,390 shares outstanding.
What happened to Humana AB’s price movement after its last earnings report?
Humana AB reported an EPS of €0.235 in its last earnings report, beating expectations of €0.204. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Humana AB?
Currently, no hedge funds are holding shares in DE:47H
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology